Sigma Healthcare (ASX:SIG) has walked away from the Boots sale process, signalling capital discipline and shifting its UK growth onto the smaller Greenlight MoU.
Large Caps
The case to invest in the big four banks was in Australia's booming property market...at least it was until the CGT changes. Much of the outrage has been over its extension to businesses and shares, but one could argue the impact on property will be more important, at least to the Big Banks.
Don't take our…
ANZ Group Holdings (ASX:ANZ) names CRO Ben Kelleher to replace retiring NZ CEO Antonia Watson, signalling a risk-first chapter for the NZ bank.
Northern Star Resources (ASX:NST) responded to Elliott Investment Management’s allegations but pushed back on a potential sale.
Treasury Wine Estates (ASX:TWE) unveils Ascent transformation, $100m cost savings, Americas strategic review and a path to 25% EBITS margins by FY30.
Ampol (ASX:ALD) wins ACCC approval for the A$1.1 billion EG Australia acquisition and switches the scrip component to cash ahead of 30 June completion.
Pro Medicus (ASX:PME) has signed a 7-year, A$16m contract with TidalHealth covering the full Visage 7 stack plus cardiology, delivered in the cloud.
Charter Hall (ASX:CHC) upgraded its FY26 OEPS guidance to $1.03 per share off the back of $6.5bn institutional inflows and FUM rising to $74.7 billion.
Brambles (ASX:BXB) cuts FY26 profit guidance on a US$60m US repair capacity hit, but announces a new US$400m on-market buyback.
Coles Group (ASX:COL) acknowledges the Federal Court ruling in the ACCC Down Down case, with pricing defence upheld but tickets ruled misleading.
